Medical News

RSS

Research: 'Pill on a string' could help detect early signs of oesophageal cancer

A 'pill on a string' developed by researchers at the University of Cambridge could help doctors detect oesophageal cancer - cancer of the gullet - at an early stage, helping them overcome the problem of wide variation between biopsies, suggests research published today in the journal Nature Genetics.

21 Jul 2015

Researchers successfully treat eczema patients using rheumatoid arthritis drug

Researchers at Yale School of Medicine have successfully treated patients with moderate to severe eczema using a rheumatoid arthritis drug recently shown to reverse two other disfiguring skin conditions, vitiligo and alopecia areata. The study is evidence of a potential new era in eczema treatment, they report.

21 Jul 2015

New drug cures malaria in mice

A new drug acts as a roadblock for malaria, curing mice of established infection, according to a study in The Journal of Experimental Medicine. Treatment was not associated with obvious side effects, suggesting that the drug may also be safe and effective in humans.

21 Jul 2015

MetLife Foundation and GHR Foundation receive Jerome H. Stone Philanthropy Award for Alzheimer's Research

The Alzheimer's Association recognizes two foundations today for their philanthropic efforts to support Alzheimer's disease research. MetLife Foundation and GHR Foundation are receiving the Jerome H. Stone Philanthropy Award for Alzheimer's Research at the Alzheimer's Association International Conference 2015 (AAIC 2015) in Washington, D.C.

21 Jul 2015

New approach holds great promise for developing effective treatments for human mitochondrial diseases

Using existing drugs, such as lithium, to restore basic biological processes in human cells and animal models, researchers may have broken a long-standing logjam in devising effective treatments for human mitochondrial diseases.

21 Jul 2015

Mothers with chemical intolerances more likely to have children with ASD or ADHD

A new study from The University of Texas Health Science Center at San Antonio found that mothers with chemical intolerances are two to three times more likely than other women to have a child with autism spectrum disorder (ASD) or attention deficit hyperactivity disorder (ADHD).

21 Jul 2015

New UTMB study finds no association between testosterone therapy and blood clots in veins

A new study from The University of Texas Medical Branch at Galveston of more than 30,000 commercially insured men is the first large comparative analysis to show that there is no link between testosterone therapy and blood clots in veins. The study found that middle-aged and older men who receive testosterone therapy are not at increased risk of this illness.

21 Jul 2015

Antibiotics may increase risk of juvenile arthritis

Taking antibiotics may increase the risk that a child will develop juvenile arthritis, according to a study from Rutgers University, University of Pennsylvania and Nemours A.I. duPont Hospital for Children published today in Pediatrics.

21 Jul 2015

New monoclonal antibodies may provide blueprint for effective Alzheimer's disease treatments

Scientists at NYU Langone Medical Center's Center for Cognitive Neurology have evidence that monoclonal antibodies they developed may provide the blueprint for effective treatments for Alzheimer's disease and other neurodegenerative diseases, such as Parkinson's disease.

21 Jul 2015

Postmenopausal adiposity benefits with increasing aerobic exercise

An aerobic exercise regimen of 300 min/week versus 150 min/week significantly improves adiposity outcomes among postmenopausal women, shows research published in JAMA Oncology.

20 Jul 2015

Children recover well from acute central nervous system demyelination

Most children can expect a good and quick physical recovery following acute central nervous system demyelination, study findings suggest.

20 Jul 2015

GE Healthcare wins 2015 North American Frost & Sullivan Market Leadership Award in Cardiology Informatics

Cardiology informatics constitutes a complex and historically siloed environment. Yet, a new generation of solutions is going beyond just supporting individual service lines, and now more efficiently integrates and manages the diverse care area workflows of the cardiology enterprise.

20 Jul 2015

XIAFLEX approved in Japan for treatment of patients with Dupuytren's contracture

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, announced that Asahi Kasei Pharma Corporation has received approval for its regulatory application to the Japanese Pharmaceutical and Medical Device Agency (PMDA) for XIAFLEX (collagenase clostridium histolyticum) for the treatment of patients with Dupuytren's contracture in Japan.

20 Jul 2015

Melphalan granted FDA Orphan Drug Designation for treatment of cholangiocarcinoma

Delcath Systems, Inc., a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announced today that the U.S. Food and Drug Administration Office of Orphan Products Development has granted Orphan Drug Designation for melphalan for the treatment of cholangiocarcinoma.

20 Jul 2015

Limelight Health secures $3 million in Series A funding from MassMutual Ventures

Limelight Health, provider of mobile enterprise technology for the health insurance industry, announced today it has received $3 million in Series A funding from MassMutual Ventures, the corporate venture capital arm of Massachusetts Mutual Life Insurance Company, and AXA Strategic Ventures.

20 Jul 2015

Inova Diagnostics announces FDA clearance for QUANTA Flash assays, QUANTA Flash Beta-2GP1 Domain1

Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, announced today that it has received 510(k) clearance by the U.S. Food and Drug Administration on key QUANTA Flash assays for use with Inova Diagnostics' BIO-FLASH chemiluminescent analyzer for autoimmune testing.

20 Jul 2015

ZEVALIN drug now available to non-Hodgkin's lymphoma patients in Hong Kong

CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that ZEVALIN is now available at hospitals in Hong Kong to patients with indicated non-Hodgkin's lymphoma (NHL), including at Hong Kong Sanatorium & Hospital.

20 Jul 2015

IAOCR announces pilot Clinical Operations Workforce Quality Accreditation at organizational level

IAOCR, the leading provider of independently recognized, competence-based accreditation, consultancy and accredited training within the clinical research sector, is pleased to announce the pilot Clinical Operations Workforce Quality Accreditation, achievement of which will serve as a quality mark for clinical operations workforce excellence. Leading contract research organization (CRO) INC Research is the first to participate in the pilot, introduced to industry specialists at the annual IAOCR Clinical Research Industry Leaders Think Tank in June.

20 Jul 2015

HeartWare announces initiation of MVAD System CE Mark international clinical trial

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced commencement of its MVAD System CE Mark international clinical trial.

20 Jul 2015

NeoGenomics announces launch of new germline cancer predisposition testing services

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today the launch of a new line of germline cancer predisposition testing services. The new tests include comprehensive testing for BRCA1 and BRCA2 encompassing an analysis of all exons and adjacent intronic regions.

20 Jul 2015

Medical News

Research: 'Pill on a string' could help detect early signs of oesophageal cancer

Researchers successfully treat eczema patients using rheumatoid arthritis drug

New drug cures malaria in mice

MetLife Foundation and GHR Foundation receive Jerome H. Stone Philanthropy Award for Alzheimer's Research

New approach holds great promise for developing effective treatments for human mitochondrial diseases

Mothers with chemical intolerances more likely to have children with ASD or ADHD

New UTMB study finds no association between testosterone therapy and blood clots in veins

Antibiotics may increase risk of juvenile arthritis

New monoclonal antibodies may provide blueprint for effective Alzheimer's disease treatments

Postmenopausal adiposity benefits with increasing aerobic exercise

Children recover well from acute central nervous system demyelination

GE Healthcare wins 2015 North American Frost & Sullivan Market Leadership Award in Cardiology Informatics

XIAFLEX approved in Japan for treatment of patients with Dupuytren's contracture

Melphalan granted FDA Orphan Drug Designation for treatment of cholangiocarcinoma

Limelight Health secures $3 million in Series A funding from MassMutual Ventures

Inova Diagnostics announces FDA clearance for QUANTA Flash assays, QUANTA Flash Beta-2GP1 Domain1

ZEVALIN drug now available to non-Hodgkin's lymphoma patients in Hong Kong

IAOCR announces pilot Clinical Operations Workforce Quality Accreditation at organizational level

HeartWare announces initiation of MVAD System CE Mark international clinical trial

NeoGenomics announces launch of new germline cancer predisposition testing services

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News